Diadema Partners »

Mannkind shares owned by Diadema Partners

Quarter-by-quarter ownership of Mannkind (MNKD) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Mannkind

Tip: Access up to 7 years of quarterly data

All positions including Mannkind held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mannkind by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.7M 1.3M 5.37

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Mannkind

BlackRock
Vanguard Group
Rubric Capital Management
State Street Corporation
Geode Capital Management
Nitorum Capital
UBS Group
venBio Select Advisor
Dimensional Fund Advisors
Wellington Management Company
FMR
TSP Capital Management Group
180 Wealth Advisors
Northern Trust
Susquehanna International

View all funds holding Mannkind